The French anti-doping agency (AFLD) has reportedly validated two aspects of its testing procedures used in the Floyd Landis case. According to L'Equipe, the first test related to the analysis of Landis' B-sample, taken after stage 17 of the 2006 Tour de France, while the second was an audit of the Isotope Ratio Mass Spectometry (IRMS) machine used to determine that Landis' samples contained synthetic testosterone.
"Following the attacks from the Landis camp, the AFLD took the initiative to require these two analyses," said AFLD president Pierre Bordry.
Thank you for reading 5 articles in the past 30 days*
Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read any 5 articles for free in each 30-day period, this automatically resets
After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59
Join now for unlimited access
Try your first month for just £1 / $1 / €1
